These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1778333)

  • 1. Japanese clinical experiences with acellular pertussis vaccines.
    Kimura M
    Dev Biol Stand; 1991; 73():5-9. PubMed ID: 1778333
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical studies on efficacy and safety of an acellular pertussis vaccine in Aichi Prefecture, Japan.
    Isomura S
    Dev Biol Stand; 1991; 73():37-42. PubMed ID: 1778331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of pertussis in Japan.
    Kimura M; Kuno-Sakai H
    Tokai J Exp Clin Med; 1988; 13 Suppl():1-7. PubMed ID: 3273609
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical studies on efficacy and safety of acellular pertussis vaccine.
    Isomura S
    Tokai J Exp Clin Med; 1988; 13 Suppl():39-43. PubMed ID: 3078809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction to the International Symposium on Pertussis Evaluation and Research on Acellular Pertussis Vaccines.
    Oya A
    Dev Biol Stand; 1991; 73():3-4. PubMed ID: 1778323
    [No Abstract]   [Full Text] [Related]  

  • 6. Acellular pertussis vaccines in Japan: past, present and future.
    Watanabe M; Nagai M
    Expert Rev Vaccines; 2005 Apr; 4(2):173-84. PubMed ID: 15889991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. American Academy of Pediatrics Committee on Infectious Diseases: The status of acellular pertussis vaccines: current perspective.
    Pediatrics; 1991 Aug; 88(2):401-5. PubMed ID: 1861950
    [No Abstract]   [Full Text] [Related]  

  • 8. Calculation of efficacy of acellular pertussis vaccine from the number of pertussis patients and vaccinees in three areas.
    Ohkuni H; Yabiku M; Togawa M; Fukai K; Yosida I; Minekawa Y; Kitamura T
    Dev Biol Stand; 1991; 73():43-9. PubMed ID: 1778332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy of the Japanese acellular pertussis vaccine after intrafamiliar exposure to pertussis patients.
    Isomura S; Suzuki S; Sato Y
    Dev Biol Stand; 1985; 61():531-7. PubMed ID: 3914964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pertussis vaccine acceptance rates and incidence of pertussis in forty seven districts (prefectures) in Japan since 1977.
    Kimura M; Kuno-Sakai H; Ozaki K
    Tokai J Exp Clin Med; 1988; 13 Suppl():9-13. PubMed ID: 3273621
    [No Abstract]   [Full Text] [Related]  

  • 11. Acellular pertussis vaccines: a turning point in infant and adolescent vaccination.
    Rappuoli R
    Infect Agents Dis; 1996 Jan; 5(1):21-8. PubMed ID: 8789596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against pertussis by Takeda's acellular pertussis vaccine: household contact studies in Kawasaki City, Japan.
    Kato T; Kaku H; Arimoto Y
    Tokai J Exp Clin Med; 1988; 13 Suppl():35-8. PubMed ID: 3078808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experiences with acellular pertussis vaccine in Japan and epidemiology of pertussis.
    Kimura M; Kuno-Sakai H
    Tokai J Exp Clin Med; 1987 Dec; 12(5-6):263-73. PubMed ID: 3508651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Japanese clinical trials with Takeda acellular pertussis vaccine.
    Kuno-Sakai H; Kimura M; Ozaki K; Isomura S; Kamiya H; Nii R; Kato T; Horiuchi K; Syukuda Y; Fujita I
    Tokai J Exp Clin Med; 1988; 13 Suppl():15-9. PubMed ID: 2908519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pertussis control in New Zealand.
    Reid S; Lennon D; Thomas M; O'Connor P; Baker M; Mansoor O
    N Z Med J; 1994 Nov; 107(989):460-2, 463-6. PubMed ID: 7970359
    [No Abstract]   [Full Text] [Related]  

  • 16. Children hospitalised with pertussis in the Bay of Plenty.
    Jarman JN
    N Z Med J; 1992 Aug; 105(940):340. PubMed ID: 1508453
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of acellular pertussis vaccine in Japan--comparison of two areas, one area where immunization started at 6 months and the other area at over 2 years of age--Regional Surveillance Committee on Tuberculosis and Infectious Diseases of Osaka.
    Ohkuni H; Kitaura T; Tamai T; Takasugi Y; Sugimoto T; Fukai K
    Tokai J Exp Clin Med; 1988; 13 Suppl():51-4. PubMed ID: 3273619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Verification of components of acellular pertussis vaccines that have been distributed solely, been in routine use for the last two decades and contributed greatly to control of pertussis in Japan.
    Kuno-Sakai H; Kimura M; Watanabe H
    Biologicals; 2004 Mar; 32(1):29-35. PubMed ID: 15026023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results with a new DTP vaccine in Japan.
    Kimura M; Hikino N
    Dev Biol Stand; 1985; 61():545-61. PubMed ID: 2872131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Eradication of whooping cough by preventive vaccination].
    Bierschenk H
    Dtsch Gesundheitsw; 1971 Oct; 26(40):1897-900. PubMed ID: 5141701
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.